文献速递消化与肝胆胰病理

肝脏移植物抗宿主病:已知知识、活检时机与诊断方法

Hepatic graft-versus-host disease: what we know, when to biopsy, and how to diagnose.
PubMed 文献 · Hum Pathol · 2023-08-02

本文综述了造血细胞移植后肝脏移植物抗宿主病(hGVHD)的发病机制、组织学特征及诊断挑战。hGVHD 诊断困难,需与正弦阻塞综合征和药物性肝损伤鉴别,肝活检组织病理学改变有助于管理复杂患者。急性 GVHD 一线治疗为类固醇,复发常见,二线治疗尚未统一。

要点

  • hGVHD 诊断需与正弦阻塞综合征和药物性肝损伤鉴别。
  • 肝活检组织学改变可帮助管理造血细胞移植后复杂患者。
  • 急性 GVHD 一线治疗为类固醇,二线治疗尚未统一。

核心结论

  • hGVHD 是造血细胞移植后严重并发症,与发病率和死亡率增加相关。
  • 准确诊断 hGVHD 对及时启动治疗和管理至关重要。

研究设计与样本

  • 本文为综述,基于文献总结 hGVHD 的已知知识、活检时机和诊断方法。

主要发现

  • hGVHD 组织学特征谱广泛,多数涉及小叶间胆管的核和胞质异常,包括胆管形态异常、凋亡和胆管细胞坏死等。
  • 肝炎型 hGVHD 通常表现为严重急性肝炎。
  • 慢性 hGVHD 可见进行性胆管丢失并最终纤维化。

临床怎么用

  • 临床和实验室检查难以区分 hGVHD 与正弦阻塞综合征和药物性肝损伤时,肝活检组织病理学信息有助于管理复杂患者。
  • 急性 GVHD 诊断成立后,一线治疗为类固醇;复发常见,类固醇耐药或依赖不罕见,二线治疗各机构不同且未统一。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Graft-versus-host disease (GVHD) is one of the serious complications that may develop after hematopoietic cell transplantation (HCT), for hematologic malignancies, solid organ transplantation, and other hematologic disorders. GVHD develops due to T lymphocytes present in the graft attacking the host antigens, which results in tissue damage. A significant number of HCT patients develop acute or chronic GVHD, which may affect multiple organs including the liver. The diagnosis of hepatic GVHD (hGVHD) is challenging as many other conditions in HCT patients may lead to liver dysfunction. Particularly challenging among the various conditions that give rise to liver dysfunction is differentiating sinusoidal obstruction syndrome and drug-induced liver injury (DILI) from hGVHD on clinical grounds and laboratory tests. Despite the minimal risks involved in performing a liver biopsy, the information gleaned from the histopathologic changes may help in the management of these very complex patients. There is a spectrum of histologic features found in hGVHD, and most involve histopathologic changes affecting the interlobular bile ducts. These include nuclear and cytoplasmic abnormalities including dysmorphic bile ducts, apoptosis, and cholangiocyte necrosis, among others. The hepatitic form of hGVHD typically shows severe acute hepatitis. With chronic hGVHD, there is progressive bile duct loss and eventually fibrosis. Accurate diagnosis of hGVHD is paramount so that timely treatment and management can be initiated. Techniques to prevent and lower the risk of GVHD from developing have recently evolved. If a diagnosis of acute GVHD is made, the first-line of treatment is steroids. Recurrence is common and steroid resistance or dependency is not unusual in this setting. Second-line therapies differ among institutions and have not been uniformly established. The development of GVHD, particularly hGVHD, is associated with increased morbidity and mortality.

来源:Hum Pathol,查看原文。版权归原作者所有。

引用

  1. Stueck AE, Fiel MI. Hepatic graft-versus-host disease: what we know, when to biopsy, and how to diagnose. Hum Pathol. 2023. PMID: 37541449. doi:10.1016/j.humpath.2023.07.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。